RECALL RECORD — CLASS IRecall closedF-1815-2017/FDA enforcement

Baidyanath Brand Arogyavardhini Bati, Dietary Supplement, 80 Tablets -- Product of India ---…

What you need to know

Class I
  • What happened

    The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. Lead is a toxic heavy metal with no safe blood lead level in children.

  • Action required

    Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure.

Recall closed · classified by the FDANY, CT, FL, HI +6 moreMore supplements

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameButala Emporium, INC.
Recalling firmButala Emporium, INC.Jackson Heights, NY, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Batch No. 018, Expiry Date 03/2017
Distribution area
NYCTFLHINJPAOHMAVTPR

NY (via 3 retail stores) and directly to 26 individual consumers (CT, FL, HI, NJ, PA, OH, MA, District of Columbia, VT & PR)

United States

Quantity affected183 bottles
Recall initiationFDA report date: April 5, 2017
FDA recall numberF-1815-2017

Beyond the headline

The recall, in context

Butala Emporium, INC. initiated this supplements recall on August 27, 2015. The FDA enforcement report states: The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits. The FDA report lists distribution as: NY (via 3 retail stores) and directly to 26 individual consumers (CT, FL, HI, NJ, PA, OH, MA, District of Columbia, VT & PR).

The FDA enforcement report describes the reason as: The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

Baidyanath Brand Arogyavardhini Bati, Dietary Supplement, 80 Tablets -- Product of India ---… was made or distributed by Butala Emporium, INC. in Jackson Heights, NY, United States. This page reflects FDA report F-1815-2017, dated April 5, 2017.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, lead is a toxic heavy metal with no safe blood lead level in children.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Lead contamination

Possible health effects

Lead can affect the nervous system and is especially harmful to children and pregnant people. Symptoms may include abdominal pain, constipation, fatigue or headaches, but some exposed people have no obvious symptoms.

When symptoms may appear

Health effects depend on the amount and duration of exposure; there is no safe blood lead level in children.

Higher-risk groups

Infants, young children, pregnant people and anyone with repeated exposure are at greatest risk.

What to do now

  1. 1Stop using or eating the affected product and prevent children from handling it.
  2. 2Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal.
  3. 3If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

Do not use home remedies or ignore possible exposure; clinical testing is the appropriate next step.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Baidyanath Brand Arogyavardhini Bati, Dietary Supplement, 80 Tablets -- Product of India ---… recall?

Butala Emporium, INC. recalled Baidyanath Brand Arogyavardhini Bati, Dietary Supplement, 80 Tablets -- Product of India ---… in an FDA Class I enforcement action reported as F-1815-2017. The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.

What should I do if I bought this product?

Stop taking the supplement. Check the lot and UPC codes below, then return it to the retailer or contact the manufacturer about a refund. Seek medical advice if you have concerns about exposure. Stop using or eating the affected product and prevent children from handling it. Keep the packaging and ask the retailer or manufacturer about a refund; follow local guidance for safe disposal. If a child or pregnant person may have been exposed, contact a healthcare professional about blood lead testing.

Is the Butala Emporium, INC. recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-1815-2017. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Butala Emporium, INC.

View brand

Related alerts

Recent Lead recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.